| PnL | ||||
|---|---|---|---|---|
 FDA approves Sanofi’s Subcutaneous Sarclisa? No 2.50 net shares | 20.0¢ / 100.0¢ | $1 (400.0%) | Apr 19, 2026 2:37 PM | |
 May 30–June 5 Yes 6.68 net shares | 11.0¢ / 0.0¢ | -$0.37 (-100.0%) | Apr 19, 2026 11:56 AM | |
 April 30 Yes 0.00 net shares | 6.0¢ / 0.0¢ | -$0 (-100.0%) | Apr 19, 2026 9:24 AM | |
 April 23 Yes -18.49 net shares | 74.0¢ / 100.0¢ | $0 (35.1%) | Apr 19, 2026 9:23 AM | |
 Roberto Sánchez Palomino No 39.99 net shares | 83.8¢ / 100.0¢ | $0 (19.3%) | Apr 19, 2026 6:52 AM | |
Roberto Sánchez Palomino Yes 40.00 net shares | 16.0¢ / 0.0¢ | -$0 (-100.0%) | Apr 19, 2026 6:49 AM |
